share_log

4: Statement of changes in beneficial ownership of securities-Officer Rokach David

4: Statement of changes in beneficial ownership of securities-Officer Rokach David

4：持股變動聲明-高管 Rokach David
美股SEC公告 ·  2024/12/21 05:06

Moomoo AI 已提取核心訊息

On December 16, 2024, David Rokach, Chief Executive Officer of Nukkleus, acquired 10,000 shares of the company's common stock at $1.39 per share. The transaction was reported as a grant, award, or other acquisition.Following this transaction, Rokach directly owns 10,000 shares of Nukkleus common stock. The total value of the acquired shares amounts to $13,900. This acquisition suggests a potential alignment of the CEO's interests with those of the shareholders.The transaction has been completed and reported as required by securities regulations. This stock acquisition by the CEO may be viewed as a positive signal about the company's future prospects, although investors should consider it alongside other financial and market information.
On December 16, 2024, David Rokach, Chief Executive Officer of Nukkleus, acquired 10,000 shares of the company's common stock at $1.39 per share. The transaction was reported as a grant, award, or other acquisition.Following this transaction, Rokach directly owns 10,000 shares of Nukkleus common stock. The total value of the acquired shares amounts to $13,900. This acquisition suggests a potential alignment of the CEO's interests with those of the shareholders.The transaction has been completed and reported as required by securities regulations. This stock acquisition by the CEO may be viewed as a positive signal about the company's future prospects, although investors should consider it alongside other financial and market information.
2024年12月16日，Nukkleus的首席執行官David Rokach以每股1.39美元購買了10,000股公司的普通股。該交易被報告爲授予、獎勵或其他收購。完成此次交易後，Rokach直接持有10,000股Nukkleus普通股。所購股票的總價值爲13,900美元。這次收購表明首席執行官的利益與股東的利益可能是一致的。該交易已按照證券法規的要求完成並報告。首席執行官的這一股票收購可能被視爲對公司未來前景的積極信號，儘管投資者應將其與其他財務和市場信息一起考慮。
2024年12月16日，Nukkleus的首席執行官David Rokach以每股1.39美元購買了10,000股公司的普通股。該交易被報告爲授予、獎勵或其他收購。完成此次交易後，Rokach直接持有10,000股Nukkleus普通股。所購股票的總價值爲13,900美元。這次收購表明首席執行官的利益與股東的利益可能是一致的。該交易已按照證券法規的要求完成並報告。首席執行官的這一股票收購可能被視爲對公司未來前景的積極信號，儘管投資者應將其與其他財務和市場信息一起考慮。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    My Size
    MYSZ
    -- 1.7900
    Baiya International Group
    BIYA
    -- 7.180
    Intellicheck
    IDN
    -- 2.880
    Applovin
    APP
    -- 272.380
    微巴士
    WETO
    -- 3.960
    解鎖完整榜單
    重估中國資產
    繼中國開創性的DeepSeek技術推出之後，華爾街大行重估對中國市場的投資前景。
    熱門討論
    中概股財報季火熱：驚喜盈利能否延續漲勢？
    1. 哪些行業可能成為本輪財報季的市場焦點？ 2. 在政府強調科技創新和可持續發展的背景下，你認為哪些行業具有最大的增長潜力？ 展开
    中國兩會：會議前後股票價格變動的關鍵要點